Sab Biotherapeutics, INC.
Biotechnology company that develops/produces antibodies for viral/bacterial infections
Based in SD
AI Overview
With $20K in lobbying spend across 7 quarterly filings, Sab Biotherapeutics, INC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2020 to 2022.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $10K |
| 2021 | $10K |
| 2022 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Sab Biotherapeutics, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Health Issues
Biomedical research funding programs within Department of Health and Human Services and Department of Defense
Food and Drug Administration policies regarding therapeutics
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.